Patent details
EP4076465 Title: ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR
Basic Information
- Publication number:
- EP4076465
- PCT Application Number:
- IB2020061957
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP208283242
- PCT Publication Number:
- WO2021124096
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR
- French Title of Invention:
- SCHÉMA DE TRAITEMENT D'UN CANCER UNE FOIS PAR JOUR AVEC UN INHIBITEUR DE PRMT5
- German Title of Invention:
- EINMAL TÄGLICHES KREBSBEHANDLUNGSREGIME MIT EINEM PRMT5-INHIBITOR
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 15/11/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 21/11/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 15/11/2023
- Unitary Effect Registration Date:
- 21/11/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 15/12/2020
- Grant date:
- 15/11/2023
- EP Publication Date:
- 26/10/2022
- PCT Publication Date:
- 24/06/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/11/2023
- EP B1 Publication Date:
- 15/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/12/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/11/2023
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
Inventor
1
- Name:
- YAMAZAKI, Shinji
- Address:
- United States (US)
2
- Name:
- LI, Meng
- Address:
- United States (US)
3
- Name:
- LIAO, Kai-Hsin
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962949688 P
- Priority Date:
- 18/12/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 202063066755 P
- Priority Date:
- 17/08/2020
- Priority Country:
- United States (US)
3
- Priority Number:
- 202063108745 P
- Priority Date:
- 02/11/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/519; A61K 31/337; A61P 35/00; A61K 9/00; A61K 39/00; A61K 9/20;
Publication
European Patent Bulletin
1
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|